respiratori
infect
remain
among
lead
caus
death
worldwid
highincom
well
middleand
lowincom
countri
wwwwhoint
addit
infect
result
import
morbid
annual
cost
associ
health
care
absente
work
estim
around
billion
unit
state
alon
manag
respiratori
infect
also
play
import
role
livestock
husbandri
aim
avoid
econom
loss
associ
poor
growth
reproduct
rate
veterinari
care
excess
mortal
larg
proport
infect
caus
virus
well
known
measl
influenza
recent
emerg
sar
nipah
prrsv
respiratori
virus
found
mani
viral
famili
restrict
respiratori
tract
use
respiratori
tract
portal
entri
establish
system
infect
mucos
immun
system
evolv
counter
infect
discuss
shintaro
sato
hiroshi
kiyono
respiratori
tract
divid
upper
lower
compart
upper
portion
colon
resid
flora
regularli
expos
inhal
pathogen
potenti
noxiou
substanc
contrast
lower
respiratori
tract
steril
cell
epitheli
layer
cover
lumin
side
respiratori
tract
welldevelop
cilia
produc
mucu
mucociliari
clearanc
result
cilialmedi
transport
mucustrap
foreign
bodi
toward
mouth
thu
repres
first
line
defens
pathogen
organ
upon
infect
respiratori
epitheli
cell
mount
vigor
innat
immun
respons
character
express
type
interferon
ifn
variou
inflammatori
cytokin
rapidli
attract
granulocyt
nk
cell
respiratori
tract
pathogen
come
contact
mucosa
taken
special
antigen
sampl
cell
process
present
antigenpres
cell
immun
effector
cell
direct
link
outer
environ
lymphat
tissu
acceler
develop
pathogenspecif
adapt
immun
respons
also
provid
respiratori
pathogen
direct
access
immun
cell
result
adapt
immun
respons
uniqu
adapt
provid
strong
mucos
defens
addit
favor
antibodi
class
switch
iga
result
iga
b
cell
express
lead
migrat
distant
epithelia
express
ligand
mucos
immun
thu
induc
iga
respons
local
well
distant
site
event
involv
repair
regener
respiratori
tissu
follow
infect
discuss
stacey
gorski
matthew
hufford
thoma
bracial
viru
replic
host
respons
contribut
death
respiratori
epitheli
resid
immun
cell
lead
loss
epitheli
barrier
integr
lung
microarchitectur
overal
regen
capac
respiratori
tract
well
document
mechan
cell
type
involv
process
start
character
elimin
viral
antigen
remov
primari
trigger
activ
innat
adapt
immun
cell
regulatori
cell
express
regulatori
cytokin
dampen
ultim
end
inflammatori
respons
subsequ
restor
respiratori
epithelium
first
involv
product
provision
matrix
cover
prolifer
epitheli
cell
activ
recruit
pulmonari
stem
cell
site
injuri
like
play
import
role
restor
also
increas
evid
process
aid
innat
immun
cell
addit
lymphoid
tissu
induc
lti
ltilik
cell
produc
tissueprotect
cytokin
type
cytokin
may
contribut
tissu
repair
via
altern
activ
macrophag
induct
measur
profibrot
respons
better
understand
regul
differ
process
could
lead
new
recoveryacceler
therapeut
approach
hendra
nipah
virus
promin
exampl
newli
emerg
pathogen
invad
host
via
respiratori
tract
establish
system
infect
review
glenn
marsh
linfa
wang
discuss
reason
underli
high
virul
broad
host
rang
virus
widespread
cellular
distribut
receptor
ephrin
allow
henipavirus
infect
almost
everi
cell
type
intracellular
activ
fusion
protein
support
rapid
celltocel
dissemin
effici
replic
spread
combin
viral
interfer
innat
immun
activ
explain
much
extrem
virul
observ
high
evolutionari
conserv
cellular
receptor
ephrin
also
provid
virus
access
broad
rang
potenti
host
speci
make
success
erad
unlik
develop
effici
treatment
safe
vaccin
thu
paramount
import
contrast
measl
viru
mev
anoth
respiratori
viru
caus
system
diseas
infect
human
certain
nonhuman
primat
rori
de
vri
ann
mesman
teuni
geijtenbeek
paul
duprex
rik
de
swart
discuss
recent
advanc
understand
mev
pathogenesi
obtain
character
gfpexpress
wild
type
virus
macaqu
appear
antigen
sampl
present
cell
respiratori
tract
initi
target
viru
follow
amplif
system
dissemin
via
immun
cell
recent
discoveri
mev
exit
receptor
illustr
import
respiratori
tract
infect
mev
egress
transmiss
henipavirus
mev
also
interfer
innat
immun
activ
strong
lymphotrop
profoundli
impact
acut
respons
produc
longterm
immunosuppress
leav
patient
vulner
secondari
viral
bacteri
infect
account
mevassoci
mortal
like
due
speciesspecif
differ
structur
cellular
receptor
efficaci
interfer
immun
recognit
mev
narrow
host
rang
make
attract
target
erad
ongo
campaign
progress
tent
target
date
porcin
reproduct
respiratori
syndrom
viru
prrsv
also
use
respiratori
tract
initi
infect
macrophag
establish
longlast
infect
lymphat
tissu
clinic
manifest
vari
subclin
lethal
depend
age
pig
presenc
pathogen
adult
anim
infect
gener
asymptomat
result
stillbirth
weak
piglet
younger
anim
respiratori
diseas
often
context
coinfect
respiratori
pathogen
predomin
ranjni
chand
benjamin
tribl
raymond
rowland
discuss
viru
escap
immun
recognit
extend
period
time
bias
antibodi
respons
structur
surfac
protein
addit
glycan
shield
neutral
epitop
recent
comparison
sequenc
reveal
high
variabl
b
cell
epitop
indic
antigen
drift
may
contribut
immun
evas
complement
inhibit
differ
innat
immun
activ
pathway
involv
sever
nonstructur
protein
factor
incorpor
develop
next
gener
vaccin
aim
lessen
impact
viru
pig
industri
sarscoronaviru
sarscov
manifest
primarili
respiratori
diseas
patient
also
experi
gastrointestin
symptom
younger
patient
develop
flulik
diseas
recov
older
individu
frequent
go
develop
acut
respiratori
distress
syndrom
ard
character
sever
dysregul
cytokin
respons
infect
interfer
differ
aspect
innat
immun
respons
discuss
allison
totura
ralph
baric
tolllik
receptor
tlr
like
involv
earli
detect
viru
transgen
mice
lack
common
adapt
molecul
experienc
sever
diseas
infect
result
rapid
induct
nfkb
transcrib
inflammatori
cytokin
activ
type
ifn
respons
delay
hour
indic
interact
differ
aspect
rigilik
receptor
signal
pathway
sever
viral
protein
contribut
observ
immunomodul
remain
unclear
constel
viru
host
factor
lead
sever
diseas
similar
sarscov
influenza
viru
trigger
excess
cytokin
respons
contribut
sever
lung
patholog
death
thij
kuiken
beatric
riteau
ron
fouchier
guu
rimmelzwaan
discuss
virushost
interact
determin
influenza
virul
season
influenza
virus
infect
mainli
upper
respiratori
tract
rapidli
control
first
innat
adapt
immun
respons
contrast
highli
pathogen
influenza
virus
target
lower
respiratori
tract
may
even
spread
organ
includ
gastrointestin
tract
central
nervou
system
infect
lower
respiratori
tract
due
receptor
specif
effici
replic
gener
lead
sever
inflammatori
respons
viru
modul
respons
exacerb
inflamm
highli
pathogen
viru
thu
potenti
elicit
selfperpetu
inflammatori
respons
ultim
result
ard
death
even
though
infecti
viru
clear
rhinovirus
belong
larg
group
pathogen
caus
common
cold
date
serotyp
identifi
explain
frequent
infect
annual
cold
outbreak
immunocompet
host
virus
restrict
upper
respiratori
tract
result
neutrophil
inflammatori
respons
lead
rhinorrhea
nasal
obstruct
individu
respiratori
comorbid
like
experi
involv
lower
respiratori
tract
character
cough
wheez
short
breath
joshua
kennedi
ronald
turner
thoma
bracial
peter
heyman
larri
borish
discuss
lack
cytopatholog
associ
rhinoviru
infect
role
host
respons
clinic
diseas
viru
kill
infect
cell
infect
result
disrupt
integr
epitheli
membran
therebi
facilit
infect
secondari
pathogen
furthermor
disrupt
may
also
give
access
basolater
surfac
epithelia
express
tlr
pattern
recognit
receptor
allergen
foreign
bodi
possibl
explain
observ
exacerb
asthma
rhinovirus
rapidli
induc
innat
immun
activ
host
result
express
type
ifn
well
chemokin
growth
factor
attract
neutrophil
eosinophil
site
infect
extent
granulocytosi
correl
diseas
sever
also
contribut
viru
clearanc
neutral
antibodi
mainli
involv
protect
reinfect
serotyp
kinet
viru
clearanc
suggest
presenc
crossreact
cell
previou
infect
serotyp
thu
vaccin
strategi
aim
elicit
reinforc
cellular
respons
conserv
epitop
could
lead
consider
reduct
morbid
henrick
schomack
ann
schaapnutt
peter
collin
alexand
schmidt
discuss
pathogenesi
human
parainfluenza
virus
hpiv
adult
hpiv
also
part
common
cold
complex
virus
caus
sever
infect
even
requir
hospit
primari
infect
infant
young
children
polar
human
airway
epithelium
cultur
hpiv
infect
ciliat
cell
caus
cytopath
effect
local
infect
combin
viral
interfer
innat
immun
activ
thought
reduc
immun
recognit
prolong
viral
replic
magnitud
viru
replic
turn
correl
diseas
sever
infect
result
develop
neutral
system
igg
mucos
iga
antibodi
one
infect
like
need
maintain
protect
mucos
immun
howev
preexist
immun
result
mild
asymptomat
diseas
upon
reinfect
pathogenesi
human
respiratori
syncyti
viru
rsv
share
mani
similar
hpiv
also
lead
sever
lower
respiratori
tract
infect
infant
young
children
caus
mostli
mild
coldlik
diseas
adult
level
replic
correl
diseas
sever
addit
nonstructur
protein
inhibit
differ
innat
immun
signal
pathway
rsv
also
produc
secret
form
envelop
glycoprotein
g
act
decoy
captur
neutral
antibodi
reduc
action
host
fraktalkin
function
tlr
antagonist
adapt
immun
respons
associ
rsv
infect
strong
bia
may
lead
predisposit
asthma
later
life
sylvia
van
drunen
littlevan
den
hurk
ellen
watkiss
discuss
uniqu
characterist
rsv
immunopatholog
regardless
phylogenet
divers
respiratori
virus
evolv
overcom
challeng
pose
uniqu
environ
respiratori
tract
advanc
genet
manipul
respect
virus
increas
avail
reagent
genom
inform
differ
host
speci
provid
excit
new
insight
underli
pathogenesi
mechan
becom
increasingli
clear
manipul
host
respons
result
sever
immunopatholog
mani
case
contribut
importantli
observ
patholog
viru
infect
